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Ontario, CanadaABSTRACT Length-dependent activation (LDA) is a prominent feature of cardiac muscle characterized by decreases in the
Ca2þ levels required to generate force (i.e., increases in Ca2þ sensitivity) when muscle is stretched. Previous studies have
concluded that LDA originates from the increased ability of (strong) cross-bridges to attach when muscle is lengthened, which
in turn enhances Ca2þ binding to the troponin C (TnC) subunit of the troponin complex. However, our results demonstrate that
inhibition of strong cross-bridge attachment with blebbistatin had no effect on the length-dependent modulation of Ca2þ sensi-
tivity (i.e., EC50) or Ca
2þ cooperativity, suggesting that LDA originates upstream of cross-bridge attachment. To test whether
LDA arises from length dependence of thin-filament activation, we replaced native cTnC with a mutant cTnC (DM-TnC) that
is incapable of binding Ca2þ. Although progressive replacement of native cTnC with DM-TnC caused an expected monotonic
decrease in the maximal force (Fmax), DM-TnC incorporation induced much larger increases in EC50 and decreases in Ca
2þ
cooperativity at short lengths than at long lengths. These findings support the conclusion that LDA arises primarily from the influ-
ence of length on the modulation of the Ca2þ cooperativity arising from interaction between adjacent troponin-tropomyosin
complexes on the thin filament.INTRODUCTIONMyofilament activation is a highly cooperative phenomenon
where force development increases steeply as a function of
the Ca2þ concentration (i.e., [Ca2þ]) (1–3). Furthermore, as
sarcomere length (SL) is increased, the amount of Ca2þ
required to produce 50% of the maximal force (EC50)
decreases (2,4,5). Since the ATPase rates per myosin
cross-bridge do not depend on SL (6,7), it appears that the
length dependence of force production originates from
alterations in the number of cross-bridges attached to the
thin filaments, a phenomenon known as length-dependent
activation (LDA). Current models of the thin filament (8)
postulate that troponin/tropomyosin (Tn/Tm) complexes
exist in three states: 1), a blocked state, wherein myosin
cannot effectively bind actin and no Ca2þ is bound to
troponin C (TnC); 2), a closed state, wherein Ca2þ is bound
to TnC, leading to a shift in Tn/Tm to expose the
myosin binding sites, but myosin is still not bound to actin;
and 3), an open state, wherein myosin has bound to actin,
thereby causing a further shift in the Tn/Tm complex.
Although early studies concluded that LDA arises from
the intrinsic Ca2þ binding properties of TnC (9,10),
subsequent studies concluded that TnC alone was not
responsible for LDA (11), suggesting that other factors are
responsible for LDA. The observation that the addition of
exogenous myosin fragments (NEM-S1) increased the
number of strongly attached cross-bridges while reducing
the level of Ca2þ required to generate force (12–15)Submitted April 27, 2010, and accepted for publication September 1, 2010.
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differences in binding properties of strongly attached
cross-bridges (16) with length. It has been postulated that
this length-dependent binding of strongly attached cross-
bridges arises from reductions in myofilament lattice
spacing that occur with increases in sarcomere length,
thus making cross-bridge attachment easier at longer
lengths (14,17). In this model, it is predicted that the
length-dependent changes in the amount of Ca2þ required
for myofilament activation are secondary to increased
cross-bridge attachment. Yet it is also conceivable that
LDA involves the influence of length on the Ca2þ-binding
properties of the Tn/Tm complexes along the thin filaments.
This Ca2þ binding is highly cooperative as a result of the
influence of end-to-end nearest-neighbor interactions
between adjacent TnC-Tn/Tm complexes on the energetics
of Ca2þ binding (18). Cross-bridge attachment to actin
within a given TnC-Tn/Tm complex can also participate
in the cooperativity of Ca2þ binding between adjacent
TnC-Tn/Tm complexes (19,20).
To dissect the mechanism for LDA, we examined the
force-Ca2þ relationship as a function of length in the pres-
ence of blebbistatin, an agent that inhibits myosin II
ATPase activity by preventing strong cross-bridge attach-
ment (21–23), and after replacing native cTnC with mutant
cTnC (DM-cTnC) that cannot bind Ca2þ. We found that
when force was inhibited with blebbistatin, estimates of the
Ca2þ sensitivity (i.e., EC50) and Hill coefficient of the
force-Ca2þ relationship were shifted by similar amounts at
short and long SLs. By contrast, increased incorporation of
DM-cTnC caused larger reductions in the Ca2þ sensitivitydoi: 10.1016/j.bpj.2010.09.003
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Our results establish that the length-dependent change in
Ca2þ-dependent myofilament activation is independent of
the number of strong-binding cross-bridges. Furthermore,
reductions in the number of TnC binding sites disrupted the
cooperativity ofmyofilament Ca2þ activationmore at shorter
sarcomere lengths, suggesting a greater dependence on
Ca2þ-dependent end-to-end (nearest-neighbor) interactions
between neighboring TnC-Tn/Tm at short versus long sarco-
mere lengths.MATERIALS AND METHODS
Skinned rat cardiac trabeculae
All experiments were performed according to institutional guidelines
concerning the care and use of experimental animals. Male rats (Sprague-
Dawley, n ¼ 40) weighing ~275–350 g received intraperitoneal injections
of 50 mg/kg sodium pentobarbital and 1.5 ml heparin (24). Under deep
anesthesia, the heart was excised, transferred to a dissection dish, and
perfused retrograde with a modified Krebs-Henseleit solution containing,
in mM, 118.5 NaCl, 5 KCl, 2 NaH2PO4, 1.2 MgSO4, 10 glucose,
26.4 NaHCO3, and 0.2 CaCl2, as well as 20 2,3-butanedione monoxime
(BDM) to inhibit spontaneous contractions. This solution, when aerated
at room temperature with a 95% O2/5% CO2 mixture, had a pH of 7.4.
Only single, isolated, unbranched trabeculae located along the exterior
wall connecting the myocardial valve to the right ventricular wall were
removed for further experiments. The muscles were placed in a dish
containing standard relaxing solution with 1% (v/v) Triton X-100 added
to chemically permeabilize all membranes to allow solutes to flow freely
into and out of the myofilament lattice.Solutions
The compositions of all solutions have been reported previously (24).
Activating solution and relaxing solution were mixed to obtain activating
solutions containing between 0.64 and 46.8 mM [Ca2þ] (pCa 6.2–4.3).cTnC double-mutant construction
For these experiments, human cDNA for cardiac TnC was used as the
starting material. The amino acid sequences for human and rat cTnC are
identical except for amino acid 119, which is isoleucine (I) in the human
isoform and methionine (M) in the rat isoform. Accordingly, the sequence
was altered by inserting a methionine in place of the isoleucine. In addition,
glutamates at positions 40 and 76 were mutated to alanines via site-directed
mutagenesis. Glu76, the last amino acid in the binding cleft of site II, was
chosen as the likely candidate for mutation, since structural studies of
TnC have demonstrated that the Glu76 position plays an important role
(25) in the N-terminal rearrangement of TnC. Glu40, which is in the defunct
site I of cardiac TnC, has been shown to be involved in the rearrangement of
the N-terminal portion of cTnC (26–28) in the presence of TnI, and was
chosen to inhibit any structural rearrangement of TnC that might be induced
by cTnI during cooperative activation of neighboring active cTn units.
Primer design
E76A.
50 GGCAGCGGCACGGTGGACTTTGATGAGTTCCTGGTCATGAT
GGTTCGGTGCA 30 (Parent)
50 GGCAGCGGCACGGTCGACTTTGATGCGTTCCTGGTCATGAT
GGTTCGGTGCA 30 (Primer)E40A.
50 GAGGATGGCTGCATCAGCACCAAGGAGCTGGGCAAGGTG
ATGAGGATGCTG 30 (Parent)
50 GAGGATGGCTGCATCAGCACCAAAGCTTTGGGCAAGGTGA
TGAGGATGCTG 30 (Primer)
Silent mutations were introduced into both primers to insert enzymatic
cut sites in the new DNA that would make identification of successful
mutagenesis quicker and easier, eliminating unnecessary sequencing
delays. For the E76A primer, the codon for glutamate (GAG) had a point
mutation inserted to convert A to C, thus converting the glutamate to an
alanine. The second point mutation converted GTG to GTC, allowing for
the introduction of a Sal I cleavage site. For the E40A primer, a little
more work was done to insert the new cut site and convert the glutamate
to an alanine. A HindIII cleavage site (AAGCTT) was inserted encompass-
ing the codon sequence for lysine-glutamate-leucine. The insertion of the
HindIII cleavage site allowed us to convert the glutamate to alanine by
switching the GAG codon to GCT, with the silent mutations in the lysine
(AAA to AAG) and leucine (CTG to TTG) codons.cTnC exchange protocol
A stock solution of TnC (either wild-type (WT) or double-mutant (DM))
was made by resuspension in relaxing solution with protease inhibitors
(protease inhibitor cocktail P8340, Sigma, St. Louis, MO) to an initial
concentration of ~2 mg/mL, and from this stock, working solutions of
200 mg/mL were prepared. To make the final working exchange solutions
used in these experiments, appropriate amounts of the DM and WT TnC
were mixed to yield double mutant/wild type mixtures of 0/100, 10/90,
25/75, 50/50, and 75/25. Endogenous cTnC was passively exchanged
(100 mL working solution) in fibers via mass action at room temperature
for 2 h. Preliminary experiments using 100% DM-cTnC were run to
measure the approximate amount of time needed. No force-Ca measure-
ments were performed in these studies.Blebbistatin studies
To further study the effects of strong-binding cross-bridges on LDA, we
used various amounts of a myosin II ATPase inhibitor, blebbistatin.
Blebbistatin, recently discovered by means of high-throughput drug
screening, is an ATPase-inhibiting agent specific for myosin (21,29–31).
The drug is stereospecific: the () stereo isoform is the active compound,
as determined by in vitro motility assay and by its ability to prevent cell
division (32). Blebbistatin has a high affinity only for the myosin II isoform,
with no appreciable reactivity for the other members of the myosin super-
family (I, V, and X) (29). Recently, we reported results from experiments on
both intact and skinned myocardial tissue, which demonstrated that blebbis-
tatin acts to inhibit force production without altering cross-bridge kinetics
or excitation-contraction coupling (22). For these experiments, the fibers
were chemically skinned for 6 h, incubated as described in Farman et al.
(22) in either 0.1, 0.4, or 1.0 mM blebbistatin overnight in dark conditions,
and mounted and viewed with red light in a light box with red filter (Kodak,
Rochester, NY).Mechanical experiments
For mechanical studies (except in the case of the blebbistatin experiments),
the muscles were incubated in the skinning solution for 14–18 h at 4C, then
transferred to fresh relaxing solution. Trabeculae 1–2 mm long and 150–
250 mm thick were attached to aluminum T-clips and then mounted on
hooks between a silicon strain gauge (AE801; SenSonor, Horten Norway)
and a servomotor (308, Cambridge Technology, Cambridge, MA; ~1 ms,
90% step response). SL was adjusted and maintained first at 2.0 5
0.02mm, then at 2.2 5 0.02 mm, during activation, using the first-order
diffraction band from a He-Ne laser (4). If the final maximal calciumBiophysical Journal 99(9) 2978–2986
2980 Farman et al.activation run generated <90% of the force of the initial full activation
(for each SL), the data for that fiber were discarded; all experiments
performed at 15C5 0.5C, a temperature known to dampen force produc-
tion (33) but used here to lower the amount of rundown in each fiber. As
previously described (24), force-[Ca2þ] relationships were fit individually
to a modified Hill equation,
Frel ¼

Ca2þ
n
=

ECn50 þ

Ca2þ
n
; (1)
where Frel is the force as a fraction of maximum force at saturating [Ca
2þ]
(Fmax), EC50 is the [Ca
2þ] at which the Frel is half of Fmax, and n is the Hill
coefficient.A BConfocal microscopy
To examine whether both our mutant and wild-type cTnC were incorpo-
rating into the skinned trabeculae uniformly, ~1 mg of each expressed
protein was labeled with an excess of maleimide fluorophores (Alexa Fluor
546, Molecular Probes, Eugene, OR) via disulfide bonds with one or both of
the cysteines on TnC, according to the protocol provided by Molecular
Probes. Adding an excess of BME to the reaction solution quenched
remaining fluorophores with the unreacted fluorophore removed via
dialysis. Fibers were incubated in either pure wild-type or pure double
mutant spiked with a fraction of the labeled protein, according to the initial
protein-exchange protocol. After incubation in the cTnC, incubated fibers
were fixed in a 3.7% formaldehyde/phosphate-buffered saline solution,
then labeled with rhodamine phalloidin (Molecular Probes) to stain for
actin; to prevent photobleaching, the fibers were then mounted in prolong
gold antifade solution (Molecular Probes). Images were obtained using
a Radiance 2100 system with a krypton laser (Bio-Rad, Hercules, CA).DC
FIGURE 1 Impact of blebbistatin on strong binding cross-bridges and the
Force-Ca relationship. Panels A and B illustrate the impact of increasing
blebbistatin concentration (0 mM circle/solid line, 1 mM squares/dashed
line) on the force calcium relationship as a functionof themaximally calcium
activated force. Blebbistatin induced a similar rightward shift in the Force-Gel analysis
To determine the amount of incorporation of DM cTnC into the
myofilament lattice, we labeled both WT cTnC and DM cTnC with Alexa
Fluor maleimide dyes (546 forWTand 488 for DM) from Invitrogen (Carls-
bad, CA). After the labeling reaction, each protein mixture was diluted to
a concentration of ~200 mg/mL, the same as the experimental protocol,
with the appropriate mixtures prepared. Fibers were incubated with
the labeled protein(s) for 2 h, at the end of which time the sample was
removed and placed in fresh relaxing solution treated with 8 M urea to
give a final urea concentration of 6 M to ensure complete dissociation of
the proteins from the myofilament lattice. To ensure complete gel separa-
tion of WT and DM cTnC, calcium was added to induce, even in the
presence of urea, a conformational change in cTnC. Samples were then
run on a 15% SDS-PAGE apparatus and imaged on a Bio-Rad molecular
imager FX. After imaging for cTnC, the gel was treated with Blue Silver
stain overnight, for total protein content, and the resulting gel was imaged
on the same system. The ratio of WT and DM cTnC in each fiber was
calculated by first normalizing the cTnC protein content in each lane.
The relative amounts of WT or DM cTnC were calculated by dividing
the relative intensity of the full DM or WT into the relative intensity
of the other lanes. The relative amount of DM to WT for each labeled
protein for each gel was averaged to give a representative amount of
exchange for the fibers.Ca relationship at both SL’s indicating no SL dependent shift, in contrast
to the results observed in DM-cTnC exchanged fibers (c.f. Fig. 3). Blebbis-
tatin induced an equal decline in the maximally activated force production
(Fmax) at both short (circles) and long (squares) lengths (Panel C) that
smoothly declined up to the maximum amount used (1 mM). As with force,
the impact of blebbistatin on EC50 (PanelD) was to decrease calcium sensi-
tivity with increasing concentration yet demonstrating no SL dependent
shifts in the EC50 as opposed to that observed inDM-cTnC exchanged fibers.
Error bars represent the mean5SE.RESULTS
Impact of reduced cross-bridge attachment
on the force-Ca2þ relationship
It is conceivable that the length-dependent differences
observed with DM-cTnC incorporation are mediated byBiophysical Journal 99(9) 2978–2986the influence of length on cross-bridge attachment. To
examine this possibility, skinned fibers were treated with
blebbistatin, a potent inhibitor of myosin II ATPase and
strong cross-bridge attachment. Fig. 1 shows the impact of
1.0 mM blebbistatin on the (normalized) force-Ca2þ
relationship and Fmax (Fig. 1, A and B, insets) on fibers at
sarcomere lengths of 2.0 mm (Fig. 1 A) and 2.2 mm
(Fig. 1 B). The relative reductions in Fmax were similar at
the two sarcomere lengths (Fig. 1 C), indicating similar
actions of blebbistatin at the two lengths. Moreover, myofil-
ament Ca2þ sensitivity, as indexed by the EC50 parameter,
was shifted by similar amounts at the two lengths
(Fig. 1 D). For example, at a concentration of 0.4 mM
blebbistatin, Fmax was reduced by ~61% at an SL of
2.0 mm and ~64% at 2.2 mm, whereas the EC50 was
increased by ~49% and ~39%, respectively. These results
support the conclusion that interference with cross-bridge
attachment has minor effects, if any, on length modulation
of Ca2þ activation properties of the myofilaments.
Based on the findings above, we speculated that LDA
might originate from length-dependence properties of the
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FIGURE 2 Incorporation of DM-cTnC into the myofilament lattice.
Panel A illustrates a typical example of SDS-PAGE gel analysis using
Blue Silver staining to visualize TnC protein. Due to the fluorescent label,
DM-TnC migrated slower allowing separation from WT-TnC. Note that
exchange with 100% DM-TnC revealed a small (~5%) amount endogenous
TnC remaining in the fiber (consistent with the virtual complete elimination
of active force development in 100% DM-TnC exchanged fibers,
c.f. Fig. 3). Fig. 2 B illustrates the percent of DM-cTnC incorporated into
the myofilament (y axis) as a function of the percent DM-cTnC used in
the exchange solution (x axis). Error bars represent the mean 5SE.
As shown, the percent of DM-cTnC incorporated into the myofilament
was linearly related to the amount of DM-cTnC in the exchange solution.
Fig. 2 C illustrates confocal images of two fibers labeled with fluorescent
WT-cTnC or fluorescent DM-cTnC (i and iv) or rhodamine phalloidin
(ii and v), as well as the merge images (iii and vi). Note the sarcomeric
pattern of the TnC labeling in comparison to the rhodamine phalloidin
staining. Merging the images demonstrates that both bacterially expressed
proteins localize to the thin filament when they are allowed to incubate with
skinned fibers.
Length-Dependent Cooperative Interaction 2981thin filament. To test this, we replaced native wild-type TnC
in isolated skinned cardiac trabeculae with varying ratios of
wild-type TnC (WT-TnC) and mutant TnC (DM-TnC)
that cannot bind Ca2þ (25). In these studies, DM-TnC and
WT-TnC were covalently labeled with Alexa-Fluor 488
and Alexa-Fluor 546, respectively, to allow imaging of the
fibers. The total concentration of bacterially expressed
WT-cTnC plus DM-cTnC was fixed at 200 mg/mL.
Fig. 2 A shows typical western blot results for isolated
skinned trabeculae that were incubated for 2 h in solutions
containing various ratios of bacterially expressed and
fluorescently labeled DM-cTnC and WT-cTnC. Note that
the estimated cTnC levels in the fibers include both the
endogenous cTnC (remaining in the fiber) and exogenous
WT-cTnC. Fig. 2 B establishes that the amount of exoge-
nous DM-TnC relative to exogenous WT-TnC incorporated
into the fiber correlated tightly with the relative amount of
DM-TnC in the solution. Moreover, the results using
solutions with 100%DM-cTnC revealed that the 2-h incuba-
tion period resulted in replacement of ~95% of the endoge-
nous cTnC by exogenous cTnC protein. Furthermore, as
illustrated in Fig. 2 C, 2-h exchange with either WT- or
DM-cTnC (200 mg/mL), covalently labeled with Alexa-
Fluor 546, resulted in a uniform distribution along the fiber
(Fig. 2 C, i and iv) and colocalized with rhodamine phalloi-
din (Fig. 2 C, iii and vi) within the myofilament lattice.
Having established that we can tightly control the
amount of DM-cTnC incorporated into the myofilament
lattice, we next examined the effects of DM-TnC on
LDA. Fig. 3 (A and B) summarizes the force-Ca2þ relation-
ships measured in fibers at SLs of 2.0 mm and 2.2mm after
incubation (for 2 h) with solutions containing several DM-
TnC/WT-TnC ratios (0/100, 10/90, and 50/50). The force
in these figures is normalized to the maximal force (i.e.,
Fmax) which is the force generated at saturating Ca
2þ levels
(i.e., ~43 mM). Consistent with previous reports on LDA
(2,34), the Ca2þ concentration required for generating
a force that is 50% of Fmax (i.e., the EC50) is lower
(P < 0.01) and the Fmax is greater (P < 0.01) at the longer
SL compared to the shorter SL when fibers are bathed in
solutions without DM-TnC. Fig. 3 shows Fmax and EC50
as a function of the DM-cTnC/cTnC ratio as measured in
fibers. It should be noted that the estimates of cTnC include
both the exogenous cTnC and the residual endogenous
cTnC remaining after the incubation period (i.e., ~5%).
Fig. 3 C demonstrates that increasing DM-cTnC incorpora-
tion causes progressive and similar reductions in Fmax at
both lengths, as expected from the loss of TnC binding sites
on the thin filament. Moreover, exchange with 100%
Dm-TnC virtually eliminated Ca2þ-activated force develop-
ment (c.f. Fig. 3). Despite similar relative reductions in Fmax
at the two lengths, DM-cTnC incorporation caused far
greater (P < 0.01) increases in EC50 (i.e., greater rightward
shifts in the force-Ca2þ relationship) at short SLs than
at longer SLs (Fig. 3 D). For example, when fibers wereBiophysical Journal 99(9) 2978–2986
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FIGURE 3 Impact of DM-cTnC incorporation on the force-Ca relation-
ship. (A and B) Impact of increasing DM-cTnC (circles, 0%; squares,
10%; diamonds, 50%) on the force-Ca relationship as a function of the
maximally calcium-activated force. The impact of DM-cTnC is greater at
the short SL (2.0 mm) (A) than at the long SL (2.2 mm) (B), with a larger
shift in the relationship to the right (lower Ca2þ sensitivity) at the short
SL with a concomitant shift in the slope (Hill coefficient). (C) The impact
of DM-cTnC incorporation into the myofilament caused an equal shift in
the maximally activated force production (Fmax) at both short (circles)
and long (squares) SLs that reached an approximate maximum at 25%
DM-cTnC incorporation. (D) The impact of DM-cTnC incorporation on
the EC50 illustrates that the reduction of force had a greater impact at short
SLs (circles) than at long SLs, indicating a large calcium dependence for
activation at short SL. Error bars represent the mean 5SE.
2982 Farman et al.bathed in solutions with a DM-TnC/WT-TnC of 50/50,
reduction of Fmax at short length (~45%) was similar to
that at long length (~38%) and the EC50 increased
(P < 0.001) from 7.40 5 0.58 to 14.94 5 1.81 mM at
SL ¼ 2.0 mm, compared with a relatively small shift (P ¼
0.17) from 5.70 5 0.48 to 7.25 5 1.86 mM at SL ¼
2.2 mm. It should be noted that when the DM-cTnC/cTnC
ratios exceeded ~0.5, we observed a large variability in
EC50, as well as in Fmax, which prevented reliable estimation
of these parameters. Yet even with these data points we
can see the impact of SL changes on the activation levels
of the myofilament lattice. Comparing the impacts of
different amounts of DM-cTnC, it can be seen that when
FMax levels (e.g., with ~10% DM-cTnC at short SL and
25% DM- cTnC at long SL in Fig. 3 C) were similar, the
EC50 values (Fig. 3 D) were still different (p < 0.05),
providing further evidence for the importance of SL changes
on the submaximal activation of the thin filament. As dis-
cussed further below, these observations have important
implications on the length dependence of Ca2þ cooperative
sarcomere activation.Biophysical Journal 99(9) 2978–2986Interplay between thick- and thin-filament
regulation on LDA
The results above establish that force inhibition byDM-cTnC
incorporation has more distinct effects on the length depen-
dence of myofilament activation than does that by blebbista-
tin. To further illustrate these differences, we plotted the
relationships between EC50 and the Hill coefficient (cooper-
ative activation) with Fmax for both blebbistatin-treated and
DM-cTnC-exchanged fibers. The rationale for this analysis
is that Fmax provides an estimate of the extent of interference
with myofilament activation, thereby allowing comparisons
between the DM-TnC interventions at the level of the thin
filament and the blebbistatin interventions at the level of
the thick filament. Fig. 4 shows that the EC50 correlated
inversely with Fmax at both sarcomere lengths for either
DM-TnC or blebbistatin treatment. This inverse relationship
between EC50 and Fmax is predicted from current models of
Ca2þ-dependent myofilament activation that arises from
the interaction between Ca2þ binding and cross-bridge
attachment (13,35). It is clear that the slope of the EC50-
Fmax relationship in the DM-cTnC-exchanged fibers at short
length (Fig. 4, blue) was much greater (P< 0.05) than for the
long sarcomere length or for the blebbistatin-treated fibers at
either length. On the other hand, the slopes of the Fmax-EC50
relationship did not differ (P¼ 0.20) between the two lengths
in the blebbistatin experiments, nor did these slopes differ
(P¼ 0.24) from the DM-TnC-exchange group at long length.
The absence of difference between the long and short lengths
in the blebbistatin group is somewhat surprising, since
previous studies had concluded that LDA results from
length-dependent difference in strong cross-bridge attach-
ment (36). It is interesting to note that the same relationship
is observed in the plot of Fmax with the Hill parameter, sug-
gesting a possible relationship between cooperativity and
calcium sensitivity. These results support the notion that
length-dependent differences in Ca2þ sensitivity arise from
the effects of length on thin-filament properties.DISCUSSION
We compared the contribution of thin-filament activation via
the troponin-tropomyosin complex to that of strong
cross-bridge attachment on the LDA in cardiac muscle.
Strong cross-bridge attachment was altered in our studies
using blebbistatin, an agent that has previously been shown
to block myosin attachment to actin and myosin ATPase
activity (21,22,29). To alter thin filament activation, we
exchanged native TnC in the skinned fibers with various
mixtures of wild-type TnC and a mutant form of TnC,
which is incapable of binding Ca2þ but which is otherwise
structurally normal (25). Under the experimental conditions
used in our replacement studies, we found a ~95% replace-
ment of endogenous TnC. Moreover, the exogenous TnC
(WT-TnC and DM-TnC) was uniformly incorporated into
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FIGURE 4 (A and B) Impact of reducing Fmax on the calcium sensitivity
(EC50) (A) and cooperative activation (n) (B) of isolated myocardial tissue.
As demonstrated, the use of blebbistatin at short (green) and long (red) SLs
reduced Fmax while having no significant impact on either the EC50 (A) or
the Hill coefficient (B), as illustrated by the shallow slopes. The use of
DM-cTnC at long sarcomere lengths (gray) mimics the impact of blebbis-
tatin, indicating that the loss of thin-filament activity at long SLs did not
have a great impact on either the calcium sensitivity or the cooperativity;
meanwhile, at short SLs (blue), the impact of DM-cTnC exchange on
calcium sensitivity (A) and cooperative activation (Hill coefficient) (B)
was severe, causing a significantly larger slope (p < 0.05) in both cases
than that observed in any of the other three groups. Error bars represent
the mean5SE.
Length-Dependent Cooperative Interaction 2983the fibers, as expected (37,38). Importantly, increasing the
ratios of mutant DM-TnC to WT-TnC in the bathing solu-
tion proportionally increased the amount of DM-TnC incor-
poration into the fiber leading to an progressive decreases in
Fmax as a result of reduced numbers of functional troponin/
tropomyosin (Tn/Tm) complexes. Consistent with our
ability to displacement most of the endogenous TnC with
exogenous TnC, we found that exchange with 100%
DM-TnC abolished force development.
Although the sarcomere length (SL) of cardiac muscle
during contraction can vary between ~1.5-2.3 mm, we
purposely focused our LDA studies on lengths of 2.0 and
2.2mm in order to avoid complications associated with theeffects internal loads or restoring forces that are observed
at SL’s below ~1.9mm. The presence of these internal forces
would interfere with estimations of strongly attached cross-
bridge numbers from the measurement of developed tension
(1). Our force-Ca2þ results are consistent with previous
studies showing that the ability of Ca2þ to activate contrac-
tion (i.e., the Ca2þ affinity) improves with increasing sarco-
mere length (2,4,39,40).
As summarized in the Introduction, the basis for LDA
remains controversial, and several cooperative mechanisms
have been proposed (13,20,39,41–43). Since increased Ca2þ
sensitivity is observed with enhanced cross-bridge attach-
ment via increased rigor cross-bridges or the addition of
cross-bridge fragments, it was concluded that LDA origi-
nated from the reduced ability of strong cross-bridges to
form as SL decreases (14,36). We found that when strong
cross-bridge formation was blocked with blebbistatin, only
minor changes occurred in the EC50 and Ca
2þ cooperativity
(Hill coefficients), even with >60% force inhibition. More
important, the effect of blebbistatin was not length-depen-
dent. Indeed, shifts in EC50 and Hill coefficients induced
by SL changes were unaffected by blebbistatin at all levels
of force inhibition. Thus, although strong-binding cross-
bridges can participate in the cooperative activation of the
thin filament by pushing the troponin/tropomyosin complex
into the open conformation (16,44), our investigations
demonstrate that blocking strong cross-bridge attachment
using blebbistatin does not differentially affect the contrac-
tile system’s responsiveness to Ca2þwhen SL is varied. This
suggests, as discussed below, that Ca2þ cooperativity and
LDA arise from the properties of thin filaments. Moreover,
also as discussed below, these results suggest that feedback
of cross-bridges on Ca2þ binding and Ca2þ cooperativity
might primarily involve the weakly attached cross-bridges,
as opposed to strongly attached (force-generating) cross-
bridges as previously suggested (45). If correct, our conclu-
sion (that Ca2þ cooperativity arises from weak cross-bridge
attachment) would predict that the effects of increased rigor
cross-bridges and cross-bridge fragments on Ca2þ coopera-
tivity are mediated primarily by simultaneous alterations in
weak cross-bridge attachment.
An alternative mechanism for LDA focuses on thin fila-
ment properties. Specifically, it has been hypothesized that
movements of TnC/Tm complexes combined with end-to-
end interactions between tropomyosin leads to cooperativity
in the Ca2þ binding between nearest-neighbor Tn/Tm
complexes (3,46). In this model, the free energy of Ca2þ
binding to TnC is coupled to the energy required for the net
movement of a Tn/Tm complex, which is coupled to neigh-
boring Tn/Tm complexes via end-to-end interactions. Thus,
Ca2þ binding and Tn/Tm movement in one Tn/Tm complex
is coupled to that in neighboring complexes (47,48). We
anticipated that incorporation of exogenous mutant cTnC
(DM-TnC), which is unable to bind Ca2þ, would interfere
with transmission of the cooperativity arising fromBiophysical Journal 99(9) 2978–2986
FIGURE 5 Schematic drawing of the proposed mechanism of LDA,
showing tropomyosin (gray lines), actin (ovals), and cardiac troponin units
(tricolored rectangles). In our version of the three-state model, the impact
of calcium on the activation of the neighboring units (dashed black line) at
short SL works to activate the neighboring cTn unit, and thus, calcium
needs to bind to more Tn units (arrows), whereas at longer SL, the activa-
tion of one cTn unit, due to the proposed stiffening of the tropomyosin, is
able to activate more cTn units, thus requiring less calcium to activate the
same number of cTn units (arrows). In other words, stretching the SL theo-
retically shifts the requirement for calcium binding from every 1–2 tropo-
nins to approximately every 3–4 troponins, allowing for more binding
sites to be activated with the same levels of calcium activation.
2984 Farman et al.end-to-end interactions between Tn/Tm and thereby disrupt
Ca2þ cooperativity. Consistent with this prediction,
increased DM-TnC incorporation caused progressive
increases in EC50 and simultaneous reductions in the Hill
coefficient and Fmax at both lengths. However, the impact
of DM-TnC incorporation on the EC50 and the Hill coeffi-
cient were far more pronounced at the short sarcomere
length. This is best appreciated by plots of the EC50 or Hill
coefficients as a function of the maximal force (Fmax) gener-
ated, where Fmax accounts for the differences in force gener-
ation between the fibers (c.f. Fig. 4). It is clear that for the
ranges of DM-TnC incorporation studied, which were
limited to solutions containing >~50% DM-TnC because
of fiber instability (i.e., large variability between fibers),
EC50 and Hill coefficient depended much more steeply on
Fmax for the short than for the long sarcomere length. Regard-
less, for the range of DM-TnC incorporation used in our
studies, we observed a twofold increase in the EC50 (i.e.,
Ca2þ sensitivity) at the short sarcomere length compared
with a 40% change in EC50 at the long sarcomere length
when Fmax was reduced by ~40%. In a similar way, the Hill
coefficient (i.e., Ca2þ cooperativity) decreased far more at
the short length than at the long length. It is interesting that
the dependence of EC50 and Hill coefficient on Fmax in the
blebbistatin-treated fibers at either length was similar to
that observed at the long length in the DM-TnC group.
How canwe explain our findings that it is interferencewith
the number of TnC/Tm complexes able to bind Ca2þ, and not
strong cross-bridge attachment, that most affects Ca2þ coop-
erativity and LDA? In principle, Ca2þ cooperativity of force
generation must ultimately arise from interactions between
neighboring Tn/Tm complexes (44,49). Previous two-state
biochemical models for Tn/Tm (50,51) have linked this co-
operativity to feedback of cross-bridge attachment on Ca2þ
binding in adjacent Tn/Tm complexes wherein strong
cross-bridge attachment drives Tn/Tm into the open state,
which has a high Ca2þ-binding affinity. However, the modest
effect of blebbistatin on the Ca2þ activation properties (i.e.,
sensitivity and cooperativity) and LDA, though initially
surprising given findings in previous studies (13,14,52),
cannot be easily explained using a two-state model. On the
other hand, our results are consistent with a three-state
biochemical model wherein the states have distinct Ca2þ
binding properties and are topologically connected in a linear
manner (blocked $ closed $ open) (44,47,48). Specifi-
cally, because strong cross-bridge attachment did not affect
cooperativity, and because strong cross-bridge attachment
in this model is associated with closed-to-open-state transi-
tions, this model predicts that there are larger differences in
Ca2þ affinity between the blocked and closed states than
between the closed and open states. Thus, since closed states
are stabilized by weak cross-bridge attachment, weak-
binding cross-bridges, which are involved in blocked-to-
closed-state transitions, are predicted to be the primary
mediators of Ca2þ cooperativity, as proposed previouslyBiophysical Journal 99(9) 2978–2986(53,54). By contrast, closed-to-open-state transitions are
not expected to enhance the Ca2þ-binding affinity and coop-
erativity. This conclusion is consistent with those of studies
showing that Ca2þ cooperativity for myofilament activation
is mediated by increased probabilities of closed-state occu-
pancy of a Tn/Tm complex after Ca2þ binding to the adjacent
Tn/Tm complex (55,56). This mechanism also readily
explains the effects of exogenous myosin and rigor bridges
on Ca2þ sensitivity without invoking the need for strong
cross-bridge binding. Specifically, it is predicted that both
exogenous myosin and low ATP conditions to promote rigor
bridge formation force Tn/Tm complexes in the process of
binding to force transitions initially through the closed state
either by stoichiometric mass action or by distortion of the
cross-bridge binding equilibria with actin (due to reduced
off rates of rigor bridges when ATP is low). Consistent with
this suggestion, it has been shown that the structural impact
of rigor cross-bridges on Tn/Tm complexes is different
from that induced by cycling cross-bridges (57).
The remarkable ability of DM-TnC incorporation to
strongly influence Ca2þ sensitivity and Ca2þ cooperativity
at short, compared to long, lengths suggests that SL affects
interactions between Tn/Tm complexes. In other words,
Ca2þ cooperativity appears to depend more strongly on the
number of TnC Ca2þ binding sites at shorter SLs than at
longer SLs. These findings suggest that coupling between
adjacent Tn/Tm complexes increases with length, thereby
making activation less dependent on the number of TnC sites
with Ca2þ bound. Thus, when Ca2þ binds to a given Tn/Tm
complex, the probability of the neighboring complexes (and
beyond) to transition to the closed state is enhanced at longer
lengths due to stronger coupling (Fig. 5). In an equivalent
Length-Dependent Cooperative Interaction 2985manner, within the framework of the flexible Tn/Tm model
(49), increases of SL increase the persistence length by
reducing Tn/Tm flexibility, thereby allowing the influence
of Ca2þ binding to propagate further along the thin filament.
Regardless of the model, the propagation of activation is, of
course, aided by weak cross-bridge attachment, which
stabilizes the closed state, leading ultimately to open-state
transitions of Tn/Tm and strong cross-bridge binding. If prop-
agation of activation is indeed reduced at short SLs, we
predict, incorporation of DM-TnC molecules will cause
greater disruptions of activation at short lengths than at longer
lengths, with the effects being more pronounced at submax-
imal Ca2þ levels (i.e., affecting EC50 and Hill coefficients)
than at maximal Ca2þ levels (i.e., affecting Fmax), as shown
by our results. The mechanism for the length dependence of
the propagation of Ca2þ activation is unclear but could
involve the interactions observed between cTnT and regula-
tory light chains (58,59) or titin (60) binding to the thin fila-
ments at the Z-disc (61) and other proteins (62,63). Clearly,
further studies will be needed to assess the molecular basis
for the enhanced propagation of Ca2þ with increased SL.
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